Total elbow arthroplasty for primary and metastatic tumor - 09/05/16
, M. De Paolis , G. Drago ⁎ , C. Romagnoli , D. Donati
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Background |
Prostheses can be used in elbow reconstruction in both primary and metastatic lesions. Several authors have reported their experience with different types of implant, but not with modular prostheses.
Hypothesis |
Limb salvage using an elbow prosthesis is effective in obtaining good functional results and reliable local tumor control.
Material and methods |
Forty-seven patients treated at the Rizzoli Institute for elbow neoplasm from 1990 to 2012 were evaluated. There were 30 primary tumors (64%), 24 bone tumors and 6 soft tissue sarcomas, and 17 bone metastases. Elbow reconstruction used a modular prosthesis in 25 patients and a standard prosthesis in 22. Reconstruction was primary in 30 patients and secondary in 17.
Results |
At last control, 15 (32%) were dead of disease (DOD) at a mean follow-up of 35 months, 12 (25%) were alive with disease (AWD) at a mean follow-up of 29 months, 19 (40%) showed no evidence of disease (NED) at a mean follow-up of 80 months. Early complications were related to unexpected neurological damage, observed in 12 patients (25%): in 5 cases the deficit resolved in a mean 6 months; in the others, no or only partial recovery was observed. Two implants (4%) developed infection: 1 was treated with antibiotic therapy, and the other required implant revision. One implant showing cement extrusion was revised. In 3 patients (6%) radiography showed a radiolucent halo around the stem (2 humeral, 1 ulnar); no measures were taken, as the patients were completely asymptomatic at every follow-up. In 3 patients (6%) partial resorption of the allograft was observed on X-ray, but remained unchanged at last follow-up, without pain or functional impairment. Seven local recurrences (15%) were observed, at a mean of 16 months after surgery; 5 were treated by resection and/or radiotherapy, and 2 by amputation. Mean functional scores on MEPS and MSTS were respectively 84% and 22/30 (73%).
Conclusions |
Elbow prostheses provided better function in primary than in metastatic tumor. Elbow prosthesis reconstruction after tumor resection is a viable option both for primary and secondary bone neoplasms.
Type of study |
Therapeutic.
Level of evidence |
IV, retrospective study.
El texto completo de este artículo está disponible en PDF.Keywords : Elbow, Tumors, Prosthesis, Limb-salvage, Metastases, Modular prosthesis
Esquema
Vol 102 - N° 4
P. 459-465 - juin 2016 Regresar al número
Artículo precedente
- Deep branch of the radial nerve in lateral surgical approaches to the radial head – A cadaveric study
- F. Han, C.T. Lim, J.C. Lim, B.H. Tan, L. Shen, V.P. Kumar
- Extensive limb-sparing surgery with reconstruction for sarcoma of the hand and wrist
- M.P. Mirous, B. Coulet, M. Chammas, D. Cupissol, C. Lazerges
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.